Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- RVTY -7.4% ( beats by $0.04, beats on revs; lowers FY25 EPS guidance; raises FY25 revenue guidance ).
Other news:
- ATAI -9.5% ( Recognify life sciences provides Update on Phase 2b Trial of Inidascamine in patients with cognitive impairment associated with Schizophrenia ).
- ARLP -4% (Reports Second Quarter Financial and Operating Results; Declares Quarterly Cash Distribution of $0.60 Per Unit; and Updates 2025 Guidance ).
- ACTU -2.2% (files for 1,332,994 share common stock offering by selling shareholders).
- TNXP -1.4% ( provides operations update ).
- CNP -1.3% (announces offering of $900 mln of Convertible Senior Notes due 2028 in a private placement ).
- SRPT -1% ( FDA investigating the death of an 8-year-old boy who received Elevidys, D.E. Shaw disclosed increased stake of 5.1% (more than 5 mln shares, previously disclosed 4.4K shares) ).
- NWBI -1% ( completes acquisition of Penns Woods Bancorp (PWOD).